GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » ROA %

Tenon Medical (Tenon Medical) ROA % : -199.15% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tenon Medical's annualized Net Income for the quarter that ended in Mar. 2024 was $-14.30 Mil. Tenon Medical's average Total Assets over the quarter that ended in Mar. 2024 was $7.18 Mil. Therefore, Tenon Medical's annualized ROA % for the quarter that ended in Mar. 2024 was -199.15%.

The historical rank and industry rank for Tenon Medical's ROA % or its related term are showing as below:

TNON' s ROA % Range Over the Past 10 Years
Min: -185.82   Med: -164.18   Max: -145.88
Current: -182.9

During the past 4 years, Tenon Medical's highest ROA % was -145.88%. The lowest was -185.82%. And the median was -164.18%.

TNON's ROA % is ranked worse than
95.84% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -2.11 vs TNON: -182.90

Tenon Medical ROA % Historical Data

The historical data trend for Tenon Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical ROA % Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROA %
-149.62 -145.88 -185.82 -178.74

Tenon Medical Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -206.43 -196.06 -155.22 -183.50 -199.15

Competitive Comparison of Tenon Medical's ROA %

For the Medical Devices subindustry, Tenon Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenon Medical's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Tenon Medical's ROA % falls into.



Tenon Medical ROA % Calculation

Tenon Medical's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-15.581/( (11.089+6.345)/ 2 )
=-15.581/8.717
=-178.74 %

Tenon Medical's annualized ROA % for the quarter that ended in Mar. 2024 is calculated as:

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-14.304/( (6.345+8.02)/ 2 )
=-14.304/7.1825
=-199.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data. ROA % is displayed in the 30-year financial page.


Tenon Medical  (NAS:TNON) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-14.304/7.1825
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-14.304 / 2.876)*(2.876 / 7.1825)
=Net Margin %*Asset Turnover
=-497.36 %*0.4004
=-199.15 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Tenon Medical ROA % Related Terms

Thank you for viewing the detailed overview of Tenon Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenon Medical (Tenon Medical) Business Description

Traded in Other Exchanges
N/A
Address
104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Executives
Van Dick Steven M officer: Chief Financial Officer HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn director, officer: Chief Technology Officer 104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster director, officer: CEO and President 104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler director C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer director 9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari director 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard director 104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle director 104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke 10 percent owner ZURCHERSTRASSE 39J, SCHLIEREN V8 8952